Aker Biomarine ASA
OSE:AKBM
Intrinsic Value
The intrinsic value of one AKBM stock under the Base Case scenario is 47.01 NOK. Compared to the current market price of 57.5 NOK, Aker Biomarine ASA is Overvalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Aker Biomarine ASA
Fundamental Analysis

Revenue & Expenses Breakdown
Aker Biomarine ASA
Balance Sheet Decomposition
Aker Biomarine ASA
Current Assets | 166.3m |
Cash & Short-Term Investments | 15m |
Receivables | 55.1m |
Other Current Assets | 96.2m |
Non-Current Assets | 221.1m |
Long-Term Investments | 400k |
PP&E | 70.7m |
Intangibles | 104.3m |
Other Non-Current Assets | 45.7m |
Free Cash Flow Analysis
Aker Biomarine ASA
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Aker Biomarine ASA
Revenue
|
198.9m
USD
|
Cost of Revenue
|
-129.9m
USD
|
Gross Profit
|
69m
USD
|
Operating Expenses
|
-75.5m
USD
|
Operating Income
|
-6.5m
USD
|
Other Expenses
|
188m
USD
|
Net Income
|
181.5m
USD
|
AKBM Profitability Score
Profitability Due Diligence
Aker Biomarine ASA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Aker Biomarine ASA's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
AKBM Solvency Score
Solvency Due Diligence
Aker Biomarine ASA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Aker Biomarine ASA's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AKBM Price Targets Summary
Aker Biomarine ASA
According to Wall Street analysts, the average 1-year price target for AKBM is 79.05 NOK with a low forecast of 75.75 NOK and a high forecast of 84 NOK.
Dividends
Current shareholder yield for AKBM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one AKBM stock under the Base Case scenario is 47.01 NOK.
Compared to the current market price of 57.5 NOK, Aker Biomarine ASA is Overvalued by 18%.